Calmodulin kinase II inhibition protects against myocardial cell apoptosis in vivo

Yingbo Yang, Wei Zhong Zhu, Mei Ling Joiner, Rong Zhang, Carmine V. Oddis, Yue Hou, Jinying Yang, Edward E. Price, Linda Gleaves, Mesut Eren, Gemin Ni, Douglas E. Vaughan, Rui Ping Xiao, Mark E. Anderson

Research output: Contribution to journalArticle

102 Citations (Scopus)

Abstract

Inhibition of the multifunctional Ca2+/calmodulin-dependent protein kinase II (CaMKII) or depletion of sarcoplasmic reticulum (SR) Ca 2+ stores protects against apoptosis from excessive isoproterenol (Iso) stimulation in cultured ventricular myocytes, suggesting that CaMKII inhibition could be a novel approach to reducing cell death in conditions of increased adrenergic tone, such as myocardial infarction (MI), in vivo. We used mice with genetic myocardial CaMKII inhibition due to transgenic expression of a highly specific CaMKII inhibitory peptide (AC3-I) to test whether CaMKII was important for apoptosis in vivo. A second line of mice expressed a scrambled, inactive form of AC3-I (AC3-C). AC3-C and wild-type (WT) littermates were used as controls. AC3-I mice have reduced SR Ca2+ content and are resistant to Iso- and MI-induced apoptosis compared with AC3-C and WT mice. Phospholamban (PLN) is a target for modulation of SR Ca2+ content by CaMKII. PLN-/- mice have increased susceptibility to Iso-induced apoptosis. Verapamil pretreatment prevented Iso-induced apoptosis in PLN -/- mice, indicating the involvement of a Ca2+-dependent pathway. AC3-I and AC3-C mice were bred into a PLN-/- background. Loss of PLN increased and equalized SR Ca2+ content in AC3-I, AC3-C, and WT mice and abolished the resistance to apoptosis in AC3-I mice after MI. There was a trend (P = 0.07) for increased Iso-induced apoptosis in AC3-I mice lacking PLN compared with AC3-I mice with PLN. These findings indicate CaMKII is proapoptotic in vivo and suggest that regulation of SR Ca2+ content by PLN contributes to the antiapoptotic mechanism of CaMKII inhibition.

Original languageEnglish (US)
JournalAmerican Journal of Physiology - Heart and Circulatory Physiology
Volume291
Issue number6
DOIs
StatePublished - 2006
Externally publishedYes

Fingerprint

Calcium-Calmodulin-Dependent Protein Kinases
Calcium-Calmodulin-Dependent Protein Kinase Type 2
Apoptosis
Sarcoplasmic Reticulum
Isoproterenol
Myocardial Infarction
phospholamban
Verapamil
Adrenergic Agents
Muscle Cells
Cell Death

Keywords

  • Isoproterenol
  • Myocardial infarction
  • Phospholamban
  • Programmed cell death

ASJC Scopus subject areas

  • Physiology

Cite this

Calmodulin kinase II inhibition protects against myocardial cell apoptosis in vivo. / Yang, Yingbo; Zhu, Wei Zhong; Joiner, Mei Ling; Zhang, Rong; Oddis, Carmine V.; Hou, Yue; Yang, Jinying; Price, Edward E.; Gleaves, Linda; Eren, Mesut; Ni, Gemin; Vaughan, Douglas E.; Xiao, Rui Ping; Anderson, Mark E.

In: American Journal of Physiology - Heart and Circulatory Physiology, Vol. 291, No. 6, 2006.

Research output: Contribution to journalArticle

Yang, Y, Zhu, WZ, Joiner, ML, Zhang, R, Oddis, CV, Hou, Y, Yang, J, Price, EE, Gleaves, L, Eren, M, Ni, G, Vaughan, DE, Xiao, RP & Anderson, ME 2006, 'Calmodulin kinase II inhibition protects against myocardial cell apoptosis in vivo', American Journal of Physiology - Heart and Circulatory Physiology, vol. 291, no. 6. https://doi.org/10.1152/ajpheart.00353.2006
Yang, Yingbo ; Zhu, Wei Zhong ; Joiner, Mei Ling ; Zhang, Rong ; Oddis, Carmine V. ; Hou, Yue ; Yang, Jinying ; Price, Edward E. ; Gleaves, Linda ; Eren, Mesut ; Ni, Gemin ; Vaughan, Douglas E. ; Xiao, Rui Ping ; Anderson, Mark E. / Calmodulin kinase II inhibition protects against myocardial cell apoptosis in vivo. In: American Journal of Physiology - Heart and Circulatory Physiology. 2006 ; Vol. 291, No. 6.
@article{b61768b8592a4062893c4edc03ce5d69,
title = "Calmodulin kinase II inhibition protects against myocardial cell apoptosis in vivo",
abstract = "Inhibition of the multifunctional Ca2+/calmodulin-dependent protein kinase II (CaMKII) or depletion of sarcoplasmic reticulum (SR) Ca 2+ stores protects against apoptosis from excessive isoproterenol (Iso) stimulation in cultured ventricular myocytes, suggesting that CaMKII inhibition could be a novel approach to reducing cell death in conditions of increased adrenergic tone, such as myocardial infarction (MI), in vivo. We used mice with genetic myocardial CaMKII inhibition due to transgenic expression of a highly specific CaMKII inhibitory peptide (AC3-I) to test whether CaMKII was important for apoptosis in vivo. A second line of mice expressed a scrambled, inactive form of AC3-I (AC3-C). AC3-C and wild-type (WT) littermates were used as controls. AC3-I mice have reduced SR Ca2+ content and are resistant to Iso- and MI-induced apoptosis compared with AC3-C and WT mice. Phospholamban (PLN) is a target for modulation of SR Ca2+ content by CaMKII. PLN-/- mice have increased susceptibility to Iso-induced apoptosis. Verapamil pretreatment prevented Iso-induced apoptosis in PLN -/- mice, indicating the involvement of a Ca2+-dependent pathway. AC3-I and AC3-C mice were bred into a PLN-/- background. Loss of PLN increased and equalized SR Ca2+ content in AC3-I, AC3-C, and WT mice and abolished the resistance to apoptosis in AC3-I mice after MI. There was a trend (P = 0.07) for increased Iso-induced apoptosis in AC3-I mice lacking PLN compared with AC3-I mice with PLN. These findings indicate CaMKII is proapoptotic in vivo and suggest that regulation of SR Ca2+ content by PLN contributes to the antiapoptotic mechanism of CaMKII inhibition.",
keywords = "Isoproterenol, Myocardial infarction, Phospholamban, Programmed cell death",
author = "Yingbo Yang and Zhu, {Wei Zhong} and Joiner, {Mei Ling} and Rong Zhang and Oddis, {Carmine V.} and Yue Hou and Jinying Yang and Price, {Edward E.} and Linda Gleaves and Mesut Eren and Gemin Ni and Vaughan, {Douglas E.} and Xiao, {Rui Ping} and Anderson, {Mark E.}",
year = "2006",
doi = "10.1152/ajpheart.00353.2006",
language = "English (US)",
volume = "291",
journal = "American Journal of Physiology - Renal Fluid and Electrolyte Physiology",
issn = "1931-857X",
publisher = "American Physiological Society",
number = "6",

}

TY - JOUR

T1 - Calmodulin kinase II inhibition protects against myocardial cell apoptosis in vivo

AU - Yang, Yingbo

AU - Zhu, Wei Zhong

AU - Joiner, Mei Ling

AU - Zhang, Rong

AU - Oddis, Carmine V.

AU - Hou, Yue

AU - Yang, Jinying

AU - Price, Edward E.

AU - Gleaves, Linda

AU - Eren, Mesut

AU - Ni, Gemin

AU - Vaughan, Douglas E.

AU - Xiao, Rui Ping

AU - Anderson, Mark E.

PY - 2006

Y1 - 2006

N2 - Inhibition of the multifunctional Ca2+/calmodulin-dependent protein kinase II (CaMKII) or depletion of sarcoplasmic reticulum (SR) Ca 2+ stores protects against apoptosis from excessive isoproterenol (Iso) stimulation in cultured ventricular myocytes, suggesting that CaMKII inhibition could be a novel approach to reducing cell death in conditions of increased adrenergic tone, such as myocardial infarction (MI), in vivo. We used mice with genetic myocardial CaMKII inhibition due to transgenic expression of a highly specific CaMKII inhibitory peptide (AC3-I) to test whether CaMKII was important for apoptosis in vivo. A second line of mice expressed a scrambled, inactive form of AC3-I (AC3-C). AC3-C and wild-type (WT) littermates were used as controls. AC3-I mice have reduced SR Ca2+ content and are resistant to Iso- and MI-induced apoptosis compared with AC3-C and WT mice. Phospholamban (PLN) is a target for modulation of SR Ca2+ content by CaMKII. PLN-/- mice have increased susceptibility to Iso-induced apoptosis. Verapamil pretreatment prevented Iso-induced apoptosis in PLN -/- mice, indicating the involvement of a Ca2+-dependent pathway. AC3-I and AC3-C mice were bred into a PLN-/- background. Loss of PLN increased and equalized SR Ca2+ content in AC3-I, AC3-C, and WT mice and abolished the resistance to apoptosis in AC3-I mice after MI. There was a trend (P = 0.07) for increased Iso-induced apoptosis in AC3-I mice lacking PLN compared with AC3-I mice with PLN. These findings indicate CaMKII is proapoptotic in vivo and suggest that regulation of SR Ca2+ content by PLN contributes to the antiapoptotic mechanism of CaMKII inhibition.

AB - Inhibition of the multifunctional Ca2+/calmodulin-dependent protein kinase II (CaMKII) or depletion of sarcoplasmic reticulum (SR) Ca 2+ stores protects against apoptosis from excessive isoproterenol (Iso) stimulation in cultured ventricular myocytes, suggesting that CaMKII inhibition could be a novel approach to reducing cell death in conditions of increased adrenergic tone, such as myocardial infarction (MI), in vivo. We used mice with genetic myocardial CaMKII inhibition due to transgenic expression of a highly specific CaMKII inhibitory peptide (AC3-I) to test whether CaMKII was important for apoptosis in vivo. A second line of mice expressed a scrambled, inactive form of AC3-I (AC3-C). AC3-C and wild-type (WT) littermates were used as controls. AC3-I mice have reduced SR Ca2+ content and are resistant to Iso- and MI-induced apoptosis compared with AC3-C and WT mice. Phospholamban (PLN) is a target for modulation of SR Ca2+ content by CaMKII. PLN-/- mice have increased susceptibility to Iso-induced apoptosis. Verapamil pretreatment prevented Iso-induced apoptosis in PLN -/- mice, indicating the involvement of a Ca2+-dependent pathway. AC3-I and AC3-C mice were bred into a PLN-/- background. Loss of PLN increased and equalized SR Ca2+ content in AC3-I, AC3-C, and WT mice and abolished the resistance to apoptosis in AC3-I mice after MI. There was a trend (P = 0.07) for increased Iso-induced apoptosis in AC3-I mice lacking PLN compared with AC3-I mice with PLN. These findings indicate CaMKII is proapoptotic in vivo and suggest that regulation of SR Ca2+ content by PLN contributes to the antiapoptotic mechanism of CaMKII inhibition.

KW - Isoproterenol

KW - Myocardial infarction

KW - Phospholamban

KW - Programmed cell death

UR - http://www.scopus.com/inward/record.url?scp=33845403131&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33845403131&partnerID=8YFLogxK

U2 - 10.1152/ajpheart.00353.2006

DO - 10.1152/ajpheart.00353.2006

M3 - Article

C2 - 16861697

AN - SCOPUS:33845403131

VL - 291

JO - American Journal of Physiology - Renal Fluid and Electrolyte Physiology

JF - American Journal of Physiology - Renal Fluid and Electrolyte Physiology

SN - 1931-857X

IS - 6

ER -